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I. INTRODUCTION 
Protein kinasc C (PKC) contains a Cys-rich region 
nnalogous to the ‘zinc finger’ sequence which has been 
shown to enhance its binding to phorbol esters [I]. 
Biphasic effects of zinc ion on PKC activity have been 
reported; low concentrations being stimulntory and 
higher concentrations inhibitory [2,3]. These results are 
at variance with the findings of Speizcr et al. [4), who 
reported that zinc is only inhibitory, Our laboratory 
became interested in determining whether or not zinc 
ion was bound by a bovine brain-derived protein in- 
hibitor of PKC, protein kinase C inhibitor-l (PKCI-I) 
151, when inspection of its primary amino acid structure 
revealed the presence of a His-rich region similar to 
that of zinc-binding metalloproteinases. PKCI-I was 
shown, by radioactive zinc overlays, to bind zinc ion 
specifically over calcium and magnesium ions [S]. The 
fact that PKC and its endogenous inhibitor, PKCI-1, 
both appeared to bind zinc ion suggested that this som- 
mon property may play a role in their interaction, To 
probe this further, we have mapped the binding site of 
PKCI-1 to a His-rich region which binds one zinc ion 
per protein molecule with a & of 4.3 ,&I. This site 
represents a new zinc-binding sequence, His-X-His-X- 
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2, MATERIALS AND METHODS 
Cnrc wu rnkcn during ~bc course of thcsc studier IQ eliminate 
adventitious metal ions from water, buffers and cquipmcnt, W~I 
was distilled and filfcrcd rhrauyh R Milli-Q Type I Rcagcnt~Grndc 
WCIIC~ System (Milliporc, Dcdford, MA) until its rcsisrivity was 
16-18 MO/cm at 25°C. Duffcrs made up in this water were rcndcrcd 
metal-free by pi\SSagC over a 200 ml bed of Chclcs-100 resin [b]. 
Plastic and glassware were soaked in 20% HNOJ for several days and 
rinsed with dcrnctalircd water. Low-metal Spectra/Par molccular~ 
porous membrane dialysis tubing (Spectrum hlcdical Industries, Los 
Angeles, CA) was used after soaking in demctalizcd water until the 
zinc ion concentration was sufficiently low (see below). 
2.2. Analysis of zinc ion 
Washes of the equipment and the Chclcx-IOO-:rn+tcd reagents were 
analyzed by graphite furnace atomic absorption spcctrometry at 
213.9 nM IVarian AA-875 and GTA-95) IO ensure that they were suf- 
ficiently z&c-free. The instrument was calibrated with g zinc ion 
standard solution (Fisher Scientific, Fair Lawn, FIJ). All washes and 
reagents were determined to be less than 1,O ng/ml zinc ion before 
their use in binding experiments. 
2.3. Removal of zinc ion from proteins 
Carbonic anhydrase (Sigma, St. Louis, MO) and DKCI-1 were con- 
verted to anonrotein forms by incubation at 0.75 tng/ml in 0.1 M N- 
methylimida~ole (Sigma) and-O, 13 M dipicolinate (Aldrich Chemical, 
Milwaukee, WI) at pM 6.5 for 1 week at 4°C [7]. Protein solutions 
were then dialyzed against water (4°C) with 5 thanyes of 2 liters each 
in 72 h. Finally, the samples were prepared for zinc-binding studies 
by dialysis against 0.02 M 2-(N-morpholino)ethanesulfonic acid 
(Sigma) at pH 6.5 for 24 h. 
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6tX)-$~~rg 0r purified PKCI~I [S] in II.1 IM ammonium bisar- 
bona4r (pPt 7,8) wax digeWd wlitl IOpg blr TWXlrca4cd rrypsin 
(Cooper Biomcdiral) far 4 h nt roam 4cmpcra4urc. The rcrc~ion WI% 
tcrminared by tliluti0n with O,l% (v/v)‘rPA and directly injeetcd on- 
to h Varirrn SO00 liquid chramdlo~rapk equipped with a Hiraehi 
dioda.array dclcctar (EM Srirncc, Chcrrr Hill, P&l). The r~iomuy 
phas.e was g C4 Vydnc rcvcnrd~phnsc rolumn (0.M x 75 cm) from 
Tire Separations Group (Herpcria, CA), and the mobile pharo was 
0.1% TFA (v/v) wirh an 80 min lirlcnr gradient of&W?o nectonilrilc 
(HPLC-Brndc, Burttick and Jnckwan, Murkcyan, Ml) in 0.1% TFA 
at I ml/min. 
25. Zinc 0rcrlcly e.Y~~erittrcrrt~ 
Profcins, rryptic pcprider and r;ynthctic pcptidrr wcrc cithcr spot. 
ted or npplicd wirh vacuum 10 sheets of nicfoccllulorc (O,lpnr, 
Schlciehcr and S&elf, #cent, Nli). Snmples applied by v~euum irr- 
valved lhc use of a Bio-Dar appnri\tus (Bio-Rad, Richmond, CA) and 
washing with scvcrnl volumes of buffer. The zinc-binding reaction 
was carried aut as previously described (91. Uricfly, protein- 
impregnated nifrocellulosc sheets were soaked for 30 min in 0.01 M 
Tris-HCI (pM 7.5) and then 15 min in the same buffer plus 0. I M KC1 
and 5 /tM ??!.nCt~ (specific activity was60 pCi/mol). The sheets wcrc 
then washed 3 times for 15 min each in O,Ol M Tris-HCJ (pH 7.5) 
containing 0.1 M KCI, blo44cd dry arid exposed to X-ray film (X- 
OMAT AR, Kodak) for I h. 
2.1. Protein kitmse C uclivity may 
Rat brain PKC (isozymic, specific activity 1.9 pmoVmin/mg) was 
purchased from Lipidcx (Westfield, NJ) and stored in 20 mM Trls- 
HCJ (ppI 7.5), 0.5 mM EGTA, 0.5 mM EDTA, 10mM 
%mercaptoethanol, 10% glycerol, 0.05% Triton X-100 and 0.1 M 
NaCL Phosphorylation of histone Type III-S (Sigma) was determined 
by mixed mice4le assay [lo] using 10 ng of PKC; since this mass was 
determined to be the minimum amount needed in the linear range of 
activity (data not shown). Inhibition of this reaction was analyzed by 
pre-incubation of PKC (IS min) with synthetic pcptides (up to 
250-fold molar excess peptide: PKC) corresponding to various 
segments of PKCI-1 in the presence or absence of 1OpM ZnClz. 
Reactions were performed in 50~1 at 37°C for 15 min and stopped 
by pipetting the solution onto phosphocellulose paper. The paper was 
then rinsed, dried, and immersed in 15 ml of scintillation cocktail 
(Ultima Gold, Packard Instruments, Downers Grove, lt) and 
counted 10 min for radioactivity, 
28. Syn fhesis and purificetion ofpepfides 
Peptides corresponding to specific regions of PKCIL-I were syn- 
To dcrssminc the rc ian rcaptmiblc Per wine binding, 
tryptic lruymcnts of PKGI- 1 were tcparntcd by MPLC, 
paslcd af discrctc pcnkx (Fig. IA), md applied anta 
t~itrcaccilula,oc for hybridiaaian with “%nCl~ and wubm 
qucnt autarudisyrriphy @ia. lB), Pfml4, the otlly xam. 
plc wlrjrh gave D strotlg signal, was analyzed by FAB 
MS [S] and ahown to cmthiin a single peptide having a 
mass of2545 (data not shawn), Thr weak aigr~al in pool 
7 probably represents a non-specific interaction, since 
previous work shawcd that this pool corresponds to the 
tryptic prptidc esnttlining EDDBL”,, five contifpxis 
acidic residues f!$]. According to the primary 5tfucture 
of PKCI-I [§I, the strong ‘%n2’-binding trygtie gcp- 
tide in pool 4 corrcsgonds to chc 24 residue ffagment 
having the scrquenct: MVVNEGSDGGQSVY IWHLH 
VLGGR (residues 95-l 18). The His-rich region in this 
sequence is similar to the metal ion binding site of other 
zinc-binding proteins, and suggested to US that this 
region might play a similar role in PKCI-I. 
After validating the equilibrium gel penetration 
method using apo-carbonic anhydrase (binds zinc ion 
in a 1: I ratio [l 11, data not shown) the technique was 
applied to the analysis of PKCI-1, Zinc binding to apo- 
PKCI-I was snturablc and Scacchard transformation of 
these data (Fig. 1C) indicated that 0.97 mol of zinc 
bound 1 .O mol of apo-PKCI-1 with a dissociation con- 
stant of 4.3 BM. 
To confirm that the His-X-His-X-His sequence in 
PKCI-I (His-l09-I-W-113) was responsible for zinc 
binding, five peptides were synthesized which cor- 
responded to various regions of PKCI- 1 (Fig. 2). Three 
of these peptides included the His-rich sequence (pcp- 
tides 2,3 and 4) and two were included as controls (pep- 
tides 1 and 5). Peptidcs l-5, PKCI-1, and standard 
proteins were applied to nitrocellulose and incubated 
with 6sZnC12. Autoradiography of the filter (Fig. 3) 
revealed that PKCX-I and control proteins known to 
bind zinc (bovine serum albumin, sarbonic anhydrase, 
hemoglobin) gave positive signals, whereas the negative 
controls (trypsin, chymotrypsin) did not. More impor- 
tantly, Fig. 3 shows that peptides with the His-rich se- 
quence (peptides 2, 3 and 4) all bound zinc and those 
without that sequence (peptides 1 and 5) did not. 
Inclusion of synthetic peptides in the PKC assay at a 
%50-fold molar excess of PKC had no effect on PMC ac- 
tivity in the presence or absense of iO/cM ZnClz. Un- 
published data from this laboratory have shown that 
10 ,uM ZnCl2 is slightly Bower than that which is in- 
hibitory in the mixed micelle assay [lo], 
TIME (min) 
During the course of these experiments he removal 
of adventitious zinc proved to be vital since nearly all 
materials were contaminated with metals. The nature 
of the stoichiometry experiments demanded precise 
concentrations of zinc ion and this was possible only by 
scrupulous clean-up of reagents and equipment. Com- 





Fig, 1, identification and stoichiomctry of zinc-binding to BKCI.1. 
(A) Reversed-phase tryptic map, fractions pooled as indicated, (8) 
Pools from (A) were lyophilized and applied to nitrocellulosc as 
aliquots of 2/3 and l/3 (above and below the numbers, respectively) 
of the total sample, incubated with %ZnCl~, and subjected to 
autoradiography. (C) Scatchard plot of the binding data. Binding of 
Zn*+ (spec. act. = 8800 cpm/nmol) to ape-protein (2.5 nmol) ~85 
measured by equilibrium gel penetration. Linear regression analysis 
indicates that ? = 0.95, YlNT = 2426, and rn = 0,23. 
by atomic absorption spectroscopy before the ex- 
periments were performed. 
4. DISCIJSSIQN 
The sequence His-Val-His-Leu-His in BKCI-1 
represents a. new site for zinc binding inasmuch as it has 
There is na .pirniluri& bctw& this site and those of’ 
‘zinc-finper” proteins [I] since Cys residues do not ap- 
pear to be involved. The sire in PKCI-1 is distinct from 
the metal-binding motif (H-E-X-X-H) assigned to ainc- 
dependent mctallopcptidascs [12], In a general sense, 
however, the zinc-binding site of PKCI-1 is similar to 
other His-rich zinc-binding sites which have been 
characterized by erystallographie analysis. For exam- 
ple, proteins having catalytic functions with zinc ion in 
their active sites (c.g catboxypepcidase A, carbonic 
anhydrase) how a motif composed of two His lignnds 
separated by a stretch of one to three amino acids, a 
third His ligand (sometimes Glu) 20 residues distal to 
rhe first two, and a fourth water ligand [13]. Compar- 
ing the PKCI-1 sequence to the above, any combination 
of two imidazole ligands in the His-X-His-X-His region 
matches the spacing rcquiremcnl for the first two 
ligands. Our data indicate the third ligand is not a Glu 
or Asp since peptide 3 binds zinc as well as pcptides 2 
and 4 and does not contain any acidic residues, In fact, 
ir can be seen in Fig. 3 that peptide 3 (QSVYHVHLH 
VLGGRQ) binds zinc at the same dilution as peptides 
2 (§DGGQ§VYHVI-ILHVLGGRQMFIWPPG) and 4 
(VVNEGSDGGQSVYHVHLHVL) and therefore con- 
tains all the structure necessary for binding. Since there 
are no other potential zinc binding amino acids (His, 
Gys, Glu, or Asp) in the sequence of peptide 3, it islike- 
Iy that all three His residues participate in binding and 
the fourth ligand is water. This hypothesis is supported 
by the observation of Iyer et al. [14] that a synthetic 
cyclic heptapeptide, Gly-I-Ii+Gly-His-Gly-His-Gly, 
binds zinc ion in a 1: 1 ratio. It was further shown by 
NMR spectroscopy that all three I-Iis residues in 
GHGHGMG participate in the binding. 
PKCI-1 has previously been shown to bind zinc ion 
preferentially over magnesium or calcium ions 151. A 
physioiogical role for this binding is suggested by the 
1: 1 stoichiometry of zinc : PKCI-1 and the & of 
4.3 yM. Other zinc binding proteins are reported to 
contain micromolar .&I values [ 1 S-18] and the concen- 
Psplide 5 
piy. 3. Binding al @‘%nOl~ 10 protrinx and pcpiidcl immobilixctl on 
trstion of zinc in bovine brain is in the micromolar 
range [19]. Since PKC and PKCI-1 are both zinc- 
binding proteins, it is interesting to speculate thar they 
may be co-regulated by an intracellular zinc ion flux. 
PKC was not inhibited by peptides of PKCI-1 that con- 
tained the zinc binding site (peprides 2, 3 and 4; data 
not shown), suggesting that other regions of the 
PKCI-1 molcculc or its secondary structure are needed 
for activity, Further invcstigarions into the details of 
this interaction will provide information about the role 
FKCI-1 plays in the rnodulation of DKC. 
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